News & Views

Sort by


Increasing Diversity in Clinical Trials

A critical need exists to include more diverse populations in clinical trials to better understand the potential risks and benefits of new medicines across populations, and provide more comprehensive data sets. 


New Advances in BRCA-Mutated Cancers

PARP inhibitors are changing the standard of care for high-risk breast cancer patients, and newcomer POLQ inhibitors may offer even more treatment options.


The Digital Pharmacy Boom

Amazon has been staking out a growing presence in healthcare. But the online giant is hardly alone in the digital pharmacy world. We take a look at the growing space.
Load More